Recombinant TSLP (Ecleralimab Biosimilar) antibody

Catalog No. ABIN7829544

The Humanized Monoclonal anti-TSLP (Ecleralimab Biosimilar) antibody (ABIN7829544) specifically detects TSLP (Ecleralimab Biosimilar). The antibody is reactive with Human samples.

Quick Overview for Recombinant TSLP (Ecleralimab Biosimilar) antibody (ABIN7829544)

Target: TSLP (Ecleralimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This TSLP (Ecleralimab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-TSLP (Ecleralimab Biosimilar) Antibody

Purpose: Anti-TSLP(ecleralimab biosimilar) mAb

Isotype: IgG1

Application Details

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for TSLP (Ecleralimab Biosimilar)

Target: TSLP (Ecleralimab Biosimilar)

Alternative Name: Ecleralimab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:TSLP
Synonyms Antibody:CSJ-117,CSJ117,NOV-14,NOV14

UniProt: Q969D9